PL324340A1 - Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids - Google Patents

Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids

Info

Publication number
PL324340A1
PL324340A1 PL96324340A PL32434096A PL324340A1 PL 324340 A1 PL324340 A1 PL 324340A1 PL 96324340 A PL96324340 A PL 96324340A PL 32434096 A PL32434096 A PL 32434096A PL 324340 A1 PL324340 A1 PL 324340A1
Authority
PL
Poland
Prior art keywords
quinoxalinophosphonic
quinoxalinoalkanophosphonic
acids
novel
quinoxalinoalkanophosphonic acids
Prior art date
Application number
PL96324340A
Other languages
English (en)
Inventor
Robert Moretti
Hans Allgeier
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PL324340A1 publication Critical patent/PL324340A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL96324340A 1995-07-10 1996-07-01 Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids PL324340A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH200995 1995-07-10

Publications (1)

Publication Number Publication Date
PL324340A1 true PL324340A1 (en) 1998-05-25

Family

ID=4223780

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96324340A PL324340A1 (en) 1995-07-10 1996-07-01 Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids

Country Status (15)

Country Link
EP (1) EP0837864A1 (fr)
JP (1) JPH11508902A (fr)
KR (1) KR19990028839A (fr)
AU (1) AU6516296A (fr)
BR (1) BR9609644A (fr)
CA (1) CA2224718A1 (fr)
CZ (1) CZ5398A3 (fr)
HU (1) HUP9901345A3 (fr)
IL (1) IL122872A0 (fr)
NO (1) NO980095L (fr)
PL (1) PL324340A1 (fr)
SK (1) SK2798A3 (fr)
TR (1) TR199800022T1 (fr)
WO (1) WO1997003079A1 (fr)
ZA (1) ZA965800B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2264171T3 (es) * 1996-10-24 2006-12-16 Novartis Ag Acidos aminoalcanofosfonicos sustituidos.
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118675A (en) * 1991-02-15 1992-06-02 American Home Products Corporation Quinoxaline phosphono-amino acids
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
SK2798A3 (en) 1998-07-08
NO980095D0 (no) 1998-01-09
IL122872A0 (en) 1998-08-16
JPH11508902A (ja) 1999-08-03
TR199800022T1 (xx) 1998-05-21
CA2224718A1 (fr) 1997-01-30
MX9800332A (es) 1998-07-31
KR19990028839A (ko) 1999-04-15
NO980095L (no) 1998-03-05
AU6516296A (en) 1997-02-10
HUP9901345A2 (hu) 1999-08-30
CZ5398A3 (cs) 1998-06-17
WO1997003079A1 (fr) 1997-01-30
BR9609644A (pt) 1999-05-11
ZA965800B (en) 1997-01-10
HUP9901345A3 (en) 2000-01-28
EP0837864A1 (fr) 1998-04-29

Similar Documents

Publication Publication Date Title
IL122428A0 (en) Minizymes and minribozymes and uses thereof
HK1002864A1 (en) Water-dissoluble narobomycin ester
PL338357A1 (en) Some 5-alkyl-2-arylaminophenyloacetic acids and their derivatives
EP0708482A3 (fr) Technologie de fabrication BiCDMOS et ses structures
IL122392A0 (en) Structurally determined metallo-constructs and applications
AU6490396A (en) Substituted-pent-4-ynoic acids
EP0851759A4 (fr) Composes et procedes associes
IL113384A0 (en) Alpha-aminolakanoic acids and reduction products
ZA962768B (en) Benzonitriles and benzofluorides
EP0801644A4 (fr) Acides polyarylcarbamoylazadioques et carbamoylalcanedio ques
ZA952008B (en) 5-vinyl- and 5-ethinyl-quinolene- and -naphthyridone- carboxylic acids
GB9510830D0 (en) Proteins
PL332553A1 (en) 3-alkooxyisooxazol-4-yl-substituted 2-aminocarboxylic acids
EP0836617A4 (fr) Parevines et tachytegrines
GB9516309D0 (en) Novel compounds and process
ZA968451B (en) Novel sulfonylaminopyrimidines
ZA964862B (en) Optimized minizymes and miniribozymes and uses thereof
SI1043332T1 (sl) Dipeptidi, ki obsegajo ciklopentan-beta-aminokisline
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
EP0744125A3 (fr) Complexe d'iode et son application
GB9423372D0 (en) Proteins and their uses
AU5188296A (en) Carbopeptoids and carbonucleotoids
PL324340A1 (en) Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids
IL120903A0 (en) Fluoroalkylglycosiduronic acids and corresponding 6(3)-lactones their preparation and their uses
GB9525234D0 (en) Process compound and use